Sunhwa Kim

机构：Merck & Co., Inc., Rahway, NJ, USA (United States) · ORCID：0000-0001-8072-1278

发表论文 17 篇 · 总被引 4882 次 · h-index 8

代表论文

• Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts (2002 · Developmental Cell · 被引 2715)
• Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis (2004 · Nature · 被引 837)
• RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β (2002 · Nature · 被引 719)
• Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation (2003 · Genes & Development · 被引 284)
• Signaling crosstalk between RANKL and interferons in osteoclast differentiation. (2002 · Arthritis Research · 被引 167)
• The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF‐κB ligand–stimulated induction of nuclear factor of activated T cells c1 (2004 · Arthritis & Rheumatism · 被引 78)